Friedrich-Schiller-Universitaet Jena

Peter Wange

Werner Vogel

Karin Naumann

Wolfram Hoeland

Gunter Carl

Eggert Beleites

Juergen Vogel

Jens Gummel

Peter Zinner

Thomas Schubert

Manfred Boese

Guenther Heublein

The invention relates to inorganic-organic compound substances useful for biomedical purposes. The object of the invention is to develop inorganic-organic compound materials which overcome the disadvantages of the state of art, wherein inorganic-organic compound substances for biomedical purposes possess to a large extent specifically adjustable characteristics. Inorganic initial substances form a new solid chemical compound with organic initial substances. The inorganic initial component consists of a biocompatible silicate glass and/or a silicate glass ceramic of the system SiO.sub.2 -Al.sub.2 O.sub.3 -MgO-Na.sub.2 O/K.sub.2 O-F.sup.-, and/or a bioactive phosphate silicate glass and/or a phosphate silicate glass ceramic of the system SiO.sub.2 -Al.sub.2 O.sub.3 -MgO-Na.sub.2 O/K.sub.2 O-CaO-P.sub.2 O.sub.5 F.sup.- and/or of the system SiO.sub.2 -MgO-K.sub.2 O-F.sup.- -CaO-P.sub.2 O.sub.5, and/or a bioactive phosphate glass and/or a phosphate glass ceramic of the system P.sub.2 O.sub.5 -Al.sub.2 O.sub.3 -CaO-Na.sub.2 O/K.sub.2 O, and/or a sintred ceramic based upon tricalcium phosphate and/or apatite. The organic initial component consists of a biocompatible, monomer-free, epoxidized polymeric hydrocarbon consisting only of the elements C, H, O having an average molecular weight Mn of 2,000 to 6,000 and an epoxy equivalence EEW of 50 to 500 g. The inorganic initial component is modified by phosphoric acid.

Inorganic-organic compound substances for biomedical purposes

Growing community of inventors

Jena, Germany

Peter Wange